Back
Isomorphic Labs – AI-Driven Drug Discovery
webisomorphiclabs.com·isomorphiclabs.com/
Relevant to AI safety discourse as a prominent example of advanced AI capabilities deployed in high-stakes scientific domains; useful context for discussions on beneficial AI applications and real-world deployment risks.
Metadata
Importance: 35/100homepage
Summary
Isomorphic Labs is a DeepMind spinoff founded by Demis Hassabis that applies frontier AI, including extensions of the Nobel Prize-winning AlphaFold system, to accelerate drug discovery and molecule design. The company aims to use machine learning to model complex biological phenomena, predict drug performance, and ultimately 'solve all disease.' It represents a major real-world deployment of advanced AI capabilities in high-stakes scientific research.
Key Points
- •Founded by Demis Hassabis as a spinoff from DeepMind, building on AlphaFold's protein-structure prediction breakthroughs.
- •Develops predictive and generative AI models for drug design, including a proprietary 'Drug Design Engine' going beyond AlphaFold.
- •Has entered pharmaceutical partnerships, including a research collaboration with Johnson & Johnson.
- •Exemplifies high-capability AI deployment in life sciences, raising questions about safety, oversight, and dual-use risks.
- •Mission framed around solving all disease with AI, reflecting Hassabis's view that healthcare is the most important AI application domain.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| Demis Hassabis | Person | 45.0 |
Cached Content Preview
HTTP 200Fetched Mar 20, 20267 KB
# Solve all disease
We’re entering a new era of drug discovery — one where frontier AI can unlock deeper scientific insights, faster breakthroughs, and life-changing medicines. At Isomorphic Labs, we’re building that future.
Isomorphic Labs is here to advance human health by building on and beyond the Nobel-winning AlphaFold system.
Our interdisciplinary team of drug discovery experts and machine learning specialists has built powerful new predictive and generative AI models that accelerate scientific discovery at digital speed.
Every day, and with each new breakthrough, we’re getting closer to the promise of digital biology, and achieving our ambitious mission to one day solve all disease with the help of AI.
L
a
t
e
s
t
f
r
o
m
I
S
O
[View All](https://www.isomorphiclabs.com/news)
[The Isomorphic Labs Drug Design Engine unlocks a new frontier beyond AlphaFold\\
\\
](https://www.isomorphiclabs.com/articles/the-isomorphic-labs-drug-design-engine-unlocks-a-new-frontier)
[Isomorphic Labs Enters into a Research Collaboration with Johnson & Johnson\\
\\
](https://www.isomorphiclabs.com/articles/isomorphic-labs-enters-into-a-research-collaboration-with-johnson-johnson)
[Isomorphic Labs to appoint Max Jaderberg as President\\
\\
](https://www.isomorphiclabs.com/articles/isomorphic-labs-to-appoint-max-jaderberg-as-president)
o
u
r
g
o
a
l
## We’re using machine learning to transform drug discovery.
[work with us](https://www.isomorphiclabs.com/work-with-us)
O
U
R
L
E
A
D
E
R
S
H
I
P
### Meet the Isos powering our progress.
[Our Team](https://www.isomorphiclabs.com/our-team)
O
U
R
C
U
L
T
U
R
E
### Advance your career at a company that’s shaping the future.
[Life at Iso](https://www.isomorphiclabs.com/life-at-iso)
O
U
R
H
E
R
I
T
A
G
E
### AlphaFold broke new ground. Iso has built on it.
[Our Tech](https://www.isomorphiclabs.com/our-tech)
I
s
o
m
o
r
p
h
i
s
m
Our name comes from the belief that there is an underlying symmetry in the universe - between biology and information science. By harnessing AI’s powerful capabilities, we can use it to model complex biological phenomena in order to help design novel molecules, anticipate how drugs will perform, and develop innovative medicines to treat and cure some of the world’s m
... (truncated, 7 KB total)Resource ID:
315c1a6070c33d87 | Stable ID: MDc3NjE5Mz